Showing results (51-60 of 10,339) with videos related to
Sort By:
Pageof 1,034
Annals of the Rheumatic Diseases|July 31, 2013
HRES-1/Rab4-mediated depletion of Drp1 impairs mitochondrial homeostasis and represents a target for treatment in SLETiffany N Caza, David R Fernandez, Gergely Talaber, et al.Annals of the Rheumatic Diseases|May 23, 2012
Persistence of immunoglobulin-producing cells in parotid salivary glands of patients with primary Sjögren's syndrome after B cell depletion therapyNishath Hamza, Hendrika Bootsma, Saravanan Yuvaraj, et al.Annals of the Rheumatic Diseases|June 13, 2012
Associations of CTX-II with biochemical markers of bone turnover raise questions on its tissue origin: data from CHECK, a cohort study of early osteoarthritisWillem E van Spil, K Wiepke Drossaers-Bakker, Floris P J G LafeberAnnals of the Rheumatic Diseases|December 4, 2014
The bromodomain protein inhibitor I-BET151 suppresses expression of inflammatory genes and matrix degrading enzymes in rheumatoid arthritis synovial fibroblastsKerstin Klein, Pawel A Kabala, Aleksander M Grabiec, et al.Annals of the Rheumatic Diseases|January 1, 2015
Association between MRI-detected knee joint regional effusion-synovitis and structural changes in older adults: a cohort studyXia Wang, Leigh Blizzard, Andrew Halliday, et al.Annals of the Rheumatic Diseases|January 1, 2015
Tacrolimus versus mycophenolate mofetil for induction therapy of lupus nephritis: a randomised controlled trial and long-term follow-upChi Chiu Mok, King Yee Ying, Cheuk Wan Yim, et al.Annals of the Rheumatic Diseases|September 3, 2014
Preferential association of a functional variant in complement receptor 2 with antibodies to double-stranded DNAJian Zhao, Brendan M Giles, Rhonda L Taylor, et al.Annals of the Rheumatic Diseases|July 16, 2013
Results from systematic screening for cardiovascular risk in outpatients with rheumatoid arthritis in accordance with the EULAR recommendationsJette Primdahl, Joan Clausen, Kim Hørslev-PetersenAnnals of the Rheumatic Diseases|July 16, 2013
Non-viral opportunistic infections in new users of tumour necrosis factor inhibitor therapy: results of the SAfety Assessment of Biologic ThERapy (SABER) studyJohn W Baddley, Kevin L Winthrop, Lang Chen, et al.Annals of the Rheumatic Diseases|November 23, 2012
Implication of IL-2/IL-21 region in systemic sclerosis genetic susceptibilityLina-Marcela Diaz-Gallo, Carmen P Simeon, Jasper C Broen, et al.Pageof 1,034